Growth Hormone News and Research

RSS
Growth hormone (GH) is a protein-based peptide hormone. It stimulates growth, cell reproduction and regeneration in humans and other animals. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by the somatotroph cells within the lateral wings of the anterior pituitary gland.
Some genetic features associated with modern diseases are ancient

Some genetic features associated with modern diseases are ancient

Genetic support for insulin system role in growth hormone response

Genetic support for insulin system role in growth hormone response

Hutchinson-Gilford Progeria Syndrome can be compared to normal aging, say scientists

Hutchinson-Gilford Progeria Syndrome can be compared to normal aging, say scientists

Long years of diabetes research now ripe for reinterpretation

Long years of diabetes research now ripe for reinterpretation

Ascendis Pharma initiates TransCon Treprostinil Phase 1 study in healthy volunteers

Ascendis Pharma initiates TransCon Treprostinil Phase 1 study in healthy volunteers

FDA approves Novo Nordisk’s weight loss injection, Saxenda

FDA approves Novo Nordisk’s weight loss injection, Saxenda

Chromosome X microduplications implicated in infancy-onset gigantism

Chromosome X microduplications implicated in infancy-onset gigantism

Progression to combined pituitary hormone deficiency common in IGHD

Progression to combined pituitary hormone deficiency common in IGHD

Growth hormone boosts muscle development in Prader-Willi syndrome

Growth hormone boosts muscle development in Prader-Willi syndrome

‘Positive’ report of growth hormone in idiopathic short stature

‘Positive’ report of growth hormone in idiopathic short stature

Novartis announces FDA approval of Signifor LAR for treatment of patients with acromegaly

Novartis announces FDA approval of Signifor LAR for treatment of patients with acromegaly

Pharmacyclics receives BayBio's 2014 Pantheon DiNA Award for Outstanding Company

Pharmacyclics receives BayBio's 2014 Pantheon DiNA Award for Outstanding Company

Novo Nordisk introduces new initiative to support healthy lifestyle programming in New Jersey area

Novo Nordisk introduces new initiative to support healthy lifestyle programming in New Jersey area

IMBRUVICA-rituximab combination well tolerated in patients with relapsed or refractory MCL

IMBRUVICA-rituximab combination well tolerated in patients with relapsed or refractory MCL

Phase 2 RESONATE-17 study: IMBRUVICA (ibrutinib) improves survival in CLL patients with del 17p

Phase 2 RESONATE-17 study: IMBRUVICA (ibrutinib) improves survival in CLL patients with del 17p

Novo Nordisk reports positive data from Novoeight phase 3 study in people with haemophilia A

Novo Nordisk reports positive data from Novoeight phase 3 study in people with haemophilia A

IMBRUVICA demonstrates anti-tumor activity against multiple myeloma in Phase II study

IMBRUVICA demonstrates anti-tumor activity against multiple myeloma in Phase II study

Pharmacyclics launches informCLL registry to explore natural history of CLL patients

Pharmacyclics launches informCLL registry to explore natural history of CLL patients

Pharmacyclics wins 2014 Society for Medicines Research Award for Drug Discovery

Pharmacyclics wins 2014 Society for Medicines Research Award for Drug Discovery

Novo Nordisk announces re-launch of online patient support platform for people with diabetes

Novo Nordisk announces re-launch of online patient support platform for people with diabetes